These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18837675)

  • 1. Topical ophthalmic medications: what potential for systemic side effects and interactions with other medications?
    Goldberg I; Moloney G; McCluskey P
    Med J Aust; 2008 Oct; 189(7):356-7. PubMed ID: 18837675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
    Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
    Heart Dis; 2001; 3(6):386-97. PubMed ID: 11975823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
    Taniguchi T; Kitazawa Y
    Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic drug interactions with topical glaucoma medications.
    Gerber SL; Cantor LB; Brater DC
    Surv Ophthalmol; 1990; 35(3):205-18. PubMed ID: 1980380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiglaucoma medications: a review of safety and tolerability issues related to their use.
    Schuman JS
    Clin Ther; 2000 Feb; 22(2):167-208. PubMed ID: 10743979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
    Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
    J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of topical allergic reactions to 1% apraclonidine.
    Feibel RM
    Arch Ophthalmol; 1995 Dec; 113(12):1579-80. PubMed ID: 7487638
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary drug treatment for glaucoma: beta-blockers versus other medications.
    Stamper RL; Wigginton SA; Higginbotham EJ
    Surv Ophthalmol; 2002; 47(1):63-73. PubMed ID: 11801272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
    Good CB
    Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
    [No Abstract]   [Full Text] [Related]  

  • 11. Side effects of glaucoma medications.
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and topical ophthalmic beta adrenergic blockade.
    Bourgeois JA
    J Am Optom Assoc; 1991 May; 62(5):403-6. PubMed ID: 1687576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic effects of topical ophthalmic medications.
    Selvin BL
    South Med J; 1983 Mar; 76(3):349-58. PubMed ID: 6131541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report.
    Minish T; Herd A
    J Emerg Med; 2002 Apr; 22(3):247-9. PubMed ID: 11932086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of topical ophthalmic beta-adrenoceptor antagonists.
    Rait JL
    Aust N Z J Ophthalmol; 1999 Feb; 27(1):57-64. PubMed ID: 10080340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to topical apraclonidine in children with glaucoma.
    Wright TM; Freedman SF
    J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac safety of ophthalmic timolol.
    Mäenpää J; Pelkonen O
    Expert Opin Drug Saf; 2016 Nov; 15(11):1549-1561. PubMed ID: 27534869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
    Nygaard HA; Høvding G
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of alpha-agonists in glaucoma therapy.
    Robin AL
    Curr Opin Ophthalmol; 1997 Apr; 8(2):42-9. PubMed ID: 10168356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors.
    Guedes GB; Karan A; Mayer HR; Shields MB
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):456-61. PubMed ID: 23445203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.